When parathyroid hormone (PTH) stays elevated, it pulls too much calcium from your bones into your bloodstream, leading to a cascade of problems that can affect your skeleton, kidneys, heart, and mental health. A normal PTH level generally falls between 10 and 65 pg/mL, and levels persistently above that range signal a condition called hyperparathyroidism. The effects range from subtle fatigue and brain fog to kidney stones and weakened bones, depending on how high the levels climb and how long they stay elevated.
How PTH Raises Your Blood Calcium
PTH is produced by four tiny glands sitting behind your thyroid. Its job is to keep blood calcium in a tight range, and it does this through two main routes: your bones and your kidneys.
In bone, PTH triggers cells called osteoclasts to break down bone tissue, releasing stored calcium and phosphate into the bloodstream. It does this indirectly. PTH first binds to bone-building cells (osteoblasts), which then release a signaling molecule called RANKL. RANKL activates the bone-dissolving osteoclasts. When PTH is chronically high, this process runs on overdrive, steadily thinning your skeleton.
In the kidneys, PTH tells the distal tubules to reabsorb more calcium back into the blood instead of letting it pass into urine. It does this by activating specific calcium channels in the kidney’s filtration system. At the same time, PTH increases phosphate excretion, flushing phosphate out through urine. The net result: more calcium stays in your body, and the calcium-to-phosphate balance shifts.
Why PTH Gets Too High
There are two distinct patterns, and the distinction matters because the causes, blood work, and treatments differ.
Primary hyperparathyroidism means one or more of the parathyroid glands is overproducing hormone on its own, usually because of a benign growth (adenoma). This drives blood calcium up and phosphate down. It’s the most common cause in otherwise healthy adults.
Secondary hyperparathyroidism is a reaction to something else, most often chronic kidney disease or vitamin D deficiency. When kidneys can’t activate vitamin D properly, or when vitamin D intake is too low, calcium absorption from food drops. The parathyroid glands compensate by pumping out more PTH to pull calcium from bone instead. In this case, blood calcium is usually normal or low, while phosphate tends to be high. Research in the American Journal of Kidney Diseases found that people with vitamin D levels above 40 ng/mL had PTH levels 20% to 40% lower than those with levels below 20 ng/mL, showing how directly vitamin D status drives PTH production.
Symptoms: Stones, Bones, Groans, and Moans
Medical students learn the effects of high PTH through a classic shorthand: “stones, bones, groans, and psychic moans.” In practice, many people with mildly elevated PTH don’t notice dramatic symptoms at first. The early signs tend to be vague: fatigue, constipation, muscle weakness, and diffuse bone or joint aches. These are easy to dismiss or attribute to aging, which is why the condition often goes undetected for years.
As calcium levels climb higher or stay elevated longer, more specific problems emerge:
- Stones: Kidney stones form because excess calcium spills into urine. In one study of patients with high calcium levels, 41.5% developed kidney stones compared to just 6.8% of people with normal calcium. Elevated PTH was present in 60% of those with high calcium, underscoring the connection.
- Bones: Chronic bone breakdown leads to osteoporosis, particularly at the wrist and hip. People with primary hyperparathyroidism have a 48% higher risk of hip fracture and a 36% higher risk of other major osteoporotic fractures compared to the general population.
- Groans: Gastrointestinal complaints, especially constipation, nausea, and abdominal pain. High calcium slows the smooth muscle contractions that move food through your digestive tract.
- Psychic moans: Cognitive and mood changes, including impaired concentration, depression, anxiety, and a general mental fogginess that patients often describe as feeling “not like themselves.”
Effects on Your Heart and Blood Vessels
High PTH doesn’t just affect bones and kidneys. Excess calcium in the blood increases how strongly blood vessels respond to signals that constrict them, raising blood pressure. Over time, elevated calcium also activates processes that cause the arterial wall to stiffen and develop fibrosis. This arterial stiffening is an independent risk factor for heart attack and stroke.
There’s also a hormonal link. PTH stimulates the release of aldosterone, a hormone that causes your body to retain sodium and water. This additional mechanism can further push blood pressure up, creating a cycle where high PTH worsens cardiovascular strain from multiple angles. People with primary hyperparathyroidism have a 52% higher risk of death compared to matched controls, and cardiovascular complications are a significant driver of that increased mortality.
How High PTH Is Diagnosed
A single blood test showing elevated PTH isn’t enough for a diagnosis. Doctors look at PTH alongside blood calcium, phosphate, and vitamin D levels to distinguish primary from secondary hyperparathyroidism. In primary disease, you’ll typically see high calcium and high PTH together, a combination that shouldn’t normally exist because high calcium should suppress PTH production. In secondary disease, PTH is high but calcium is normal or low, and vitamin D is often depleted.
A 24-hour urine calcium collection helps confirm whether excess calcium is being filtered through the kidneys, and imaging studies like a sestamibi scan or neck ultrasound can locate a parathyroid adenoma if surgery is being considered.
Treatment: Surgery and Medication
For primary hyperparathyroidism, surgery to remove the overactive gland (parathyroidectomy) is the definitive treatment and is recommended for all symptomatic patients. Current guidelines from the American Association of Endocrine Surgeons suggest it should also be considered for most asymptomatic patients, since it is more cost-effective than long-term observation or medication.
The surgery has excellent results. Minimally invasive techniques achieve cure rates between 98% and 99%, with low complication rates. The most common issue after surgery is a temporary drop in calcium as the remaining parathyroid glands “wake up” after being suppressed, but this resolves on its own in most cases. Permanent complications like nerve damage to the vocal cords occur in fewer than 1% of procedures. Most people go home the same day or the next morning.
When surgery isn’t an option, whether due to other health conditions or patient preference, a medication called cinacalcet can help. It works by mimicking calcium at the sensors on the parathyroid glands, essentially tricking them into thinking calcium levels are higher than they are. This suppresses PTH secretion and lowers blood calcium. It’s FDA-approved for secondary hyperparathyroidism in people with end-stage kidney disease and for primary hyperparathyroidism when surgery isn’t feasible.
Secondary Hyperparathyroidism Treatment
When high PTH is a response to vitamin D deficiency, the fix is straightforward: replenishing vitamin D. This restores the body’s ability to absorb calcium from food, removing the stimulus that was driving PTH production up. The target vitamin D level is generally above 40 ng/mL, the threshold where PTH levels drop most significantly.
For people with chronic kidney disease, the picture is more complex. Damaged kidneys can’t convert vitamin D to its active form efficiently, and they retain too much phosphate. Treatment typically involves active vitamin D supplements, phosphate-lowering medications, and sometimes cinacalcet. The goal is to bring PTH into a manageable range and prevent the bone disease and vascular calcification that come with years of unchecked secondary hyperparathyroidism.
What Happens if You Don’t Treat It
Left unchecked, high PTH continues to leach calcium from your skeleton, progressively weakening bones and increasing fracture risk year after year. Kidney stones can recur and, in severe cases, lead to kidney damage. Cardiovascular risks accumulate as arteries stiffen and blood pressure rises. The cognitive and mood effects can quietly erode quality of life in ways that only become obvious in retrospect, after treatment.
Even in people who feel fine, the damage is often happening silently. Bone density scans may show thinning at the wrist or hip before any fracture occurs. Kidney function may gradually decline. This is why most endocrine surgeons now lean toward treating the condition rather than simply monitoring it, even in the absence of obvious symptoms.